cell-bound complement activation products

March 7, 2016March 7, 2016

Fibromyalgia Distinguished from Lupus with 100% Specificity Using New Test

News

California researchers found that analyzing cell-bound complement activation products (CB-CAPs) ably distinguishes between systemic lupus erythematosus (SLE) and fibromyalgia (FM), and complements current test methods. Whereas fibromyalgia and lupus might share non-specific symptoms, the ... Read more

February 12, 2016February 12, 2016

New Test Accurately Distinguishes Fibromyalgia From Lupus

News

A recent study found it is possible to distinguish systemic lupus erythematosus (SLE) patients from those with primary fibromyalgia (FM), with complete specificity, using a new test measuring the levels of ... Read more